Cadrenal Therapeutics CVKD
NASDAQ CVKD
$0.95 -0.02 (-2.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cadrenal Therapeutics (CVKD) Interest & Investment Income (2022 - 2026)

Updated

Cadrenal Therapeutics' Interest & Investment Income was $17,835 in Q2 2026, down 73.4% from $67,004 a year earlier.

Analysis

Cadrenal Therapeutics (CVKD) Interest & Investment Income (2022 - 2026) Analysis & Trends

On a trailing twelve-month basis, Cadrenal Therapeutics' Interest & Investment Income was $210,604 through Jun 30, 2026, down 26.1% year-over-year; for FY2023, it was $249,092.

  • In earlier years, Interest & Investment Income was $21.00 in FY2022.
  • The Q2 2026 figure marks the lowest quarterly Interest & Investment Income since Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Cadrenal Therapeutics 2.94 Mn -9.67 Mn - 17,835.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17,835.00
Jun 30, 2025 67,004.00
Sep 30, 2024 52,129.00
Jun 30, 2024 73,636.00
Mar 31, 2024 92,327.00
Dec 31, 2023 119,771.00
Sep 30, 2023 106,145.00
Jun 30, 2023 23,176.00
Dec 31, 2022 1.00
Sep 30, 2022 3.00
API Access

Cadrenal Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CVKD&period=max&api_key=YOUR_API_KEY